CASI Pharmaceuticals Inc. (CASI) gained 21.81% on Tuesday, following a $50 million private placement. The financing was led by ETP Global Fund LP, IDG-Accel China Growth Fund III, and Robert W. Duggan, former Chairman and CEO of Pharmacyclics Inc., and is expected to close on or about March 21, 2018.
from RTT - Biotech http://ift.tt/2FS6vmw
via IFTTT
No comments:
Post a Comment